Sera Prognostics (SERA) Gross Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 58.00 |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | 356,842.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 356,842.00 |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | -587,759.00 |
| Jun 30, 2025 | -1.06 Mn |
| Dec 31, 2024 | -625,285.00 |
| Sep 30, 2024 | -84,622.00 |
| Jun 30, 2024 | 225,163.00 |
| Dec 31, 2023 | 151,951.00 |
| Sep 30, 2023 | 18,415.00 |
| Jun 30, 2023 | 307,402.00 |
| Mar 31, 2023 | 891,358.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 828,531.00 |
| Jun 30, 2022 | 329,103.00 |
| Mar 31, 2022 | -134,696.00 |
| Dec 31, 2021 | -64,231.00 |
| Sep 30, 2021 | 938,435.00 |
| Jun 30, 2021 | 316,667.00 |